Evidence map›Paper›PMID 3579261›Full record

Trial reportAntimicrobial agents and chemotherapy1987

Erythromycin-resistant Campylobacter infections in Thailand.

D N Taylor, M J Blaser, P Echeverria, C Pitarangsi, L Bodhidatta, W L Wang

Open access · greenAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Consequences of Shigella infection in young children: a systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Pooled it
  2. Pooled it
  3. Prevalence and antimicrobial resistance ofOne health (Amsterdam, Netherlands) · 2025
    Review
  4. Article
  5. Article
  6. Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1996
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 1992
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mechanisms of antibiotic resistance in Campylobacter species.Antimicrobial agents and chemotherapy · 1988
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

D N Taylor
M J Blaser
P Echeverria
C Pitarangsi
L Bodhidatta
W L Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythromycin therapy was compared with no treatment in a prospective trial of acute diarrheal disease among 100 infants in an orphanage in Bangkok. Within 24 h of the onset of diarrhea, 50 children received erythromycin ethylsuccinate (40 mg/kg per day) in four divided doses for 5 days. Campylobacter jejuni isolated from 31, Campylobacter coli isolated from 21, and Shigella spp. isolated from 21 of 100 children were the most commonly recognized pathogens; use of a sensitive, nonselective method substantially increased Campylobacter isolation. Treatment with erythromycin had no effect on the duration of diarrhea caused by Campylobacter spp., Shigella spp., or other agents; 37% of the treatment group and 35% of the control group had diarrhea for 1 week. Of 23 Campylobacter strains isolated from the treatment group before treatment, 15 (65%) were resistant (MIC, greater than or equal to 8 micrograms/ml) to erythromycin. Among orphanage-acquired strains, 53% of 43 C. jejuni strains and 91% of 23 C. coli strains were resistant to erythromycin compared with 11% of 114 C. jejuni strains and 46% of 35 C. coli strains that were community acquired. Erythromycin resistance is common among Campylobacter strains in Bangkok, especially in an institutional setting, which may account for the lack of efficacy of erythromycin for treatment of acute diarrheal illnesses.

Indexed as

CampylobacterCampylobacter InfectionsChild, PreschoolDiarrheaDrug Resistance, MicrobialDysentery, BacillaryErythromycinHumansInfantMicrobial Sensitivity TestsThailandErythromycin

Identifiers

PMID3579261
PMCPMC174747
OpenAlexW2153996284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.